Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort

Environment International

Volumn 37, Issue 1, 2011, Pages 129-135

  Christensen, Krista Yorita ^a   Maisonet, Mildred ^a,b   Rubin, Carol ^b   Holmes, Adrianne ^b   Calafat, Antonia M ^b   Kato, Kayoko ^b   Flanders, W Dana ^a,b   Heron, Jon ^c   McGeehin, Michael A ^b   Marcus, Michele ^a,b  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

ALSPAC; Menarche; Polyfluoroalkyl chemicals

Indexed keywords

BODY FLUIDS; CARBOXYLATION; CHEMICALS; CONSUMER PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OBSTETRICS; PHASE SEPARATION; STATISTICAL METHODS; SULFUR COMPOUNDS;

ALSPAC; ENDOCRINE DISRUPTOR; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRIES; LOGISTIC REGRESSIONS; MENARCHE; ON-LINE SOLID PHASE EXTRACTION; PERFLUOROOCTANE SULFONAMIDE; SERUM CONCENTRATION;

CHROMATOGRAPHY;

CARBOXYLIC ACID DERIVATIVE; CHEMICAL COMPOUND; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; POLYFLUOROALKYL DERIVATIVE; SULFONAMIDE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

CHEMICAL POLLUTANT; ENDOCRINE DISRUPTOR; POLLUTION EXPOSURE; PREGNANCY; SERUM;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CAUCASIAN; CHILD; CHILDBIRTH; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LONGITUDINAL STUDY; MATERNAL BLOOD; MENARCHE; ONSET AGE; POPULATION BASED CASE CONTROL STUDY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; UNITED KINGDOM;

UNITED KINGDOM;

EID: 78349313606     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2010.08.007     Document Type: Article

References (46)

1. Andersen M.E., Butenhoff J.L., Chang S.C., et al. Perfluoroalkyl acids and related chemistries-toxicokinetics and modes of action. Toxicol Sci 2008, 102:3-14.
2. Austin M.E., Kasturi B.S., Barber M., Kannan K., MohanKumar P.S., MohanKumar S.M. Neuroendocrine effects of perfluorooctane sulfonate in rats. Environ Health Perspect 2003, 111:1485-1489.
3. Avon Longitudinal Study of Parents and Children. University of Bristol, Department of Social Medicine. (Accessed September 22, 2008, at). http://www.bristol.ac.uk/alspac/.
4. Barker D.J. Maternal nutrition, fetal nutrition, and disease in later life. Nutrition 1997, 13:807-813. (Burbank, Los Angeles County, Calif).
5. Biegel L.B., Liu R.C., Hurtt M.E., Cook J.C. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol Appl Pharmacol 1995, 134:18-25.
6. Biegel L.B., Hurtt M.E., Frame S.R., O'Connor J.C., Cook J.C. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol Sci 2001, 60:44-55.
7. Biro F.M., McMahon R.P., Striegel-Moore R., et al. Impact of timing of pubertal maturation on growth in black and white female adolescents: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr 2001, 138:636-643.
8. Biro F.M., Lucky A.W., Simbartl L.A., et al. Pubertal maturation in girls and the relationship to anthropometric changes: pathways through puberty. J Pediatr 2003, 142:643-646.
9. Biro F.M., Khoury P., Morrison J.A. Influence of obesity on timing of puberty. Int J Androl 2006, 29:272-277. (discussion 86-90).
10. Biro F.M., Huang B., Crawford P.B., et al. Pubertal correlates in black and white girls. J Pediatr 2006, 148:234-240.
11. Bookstaff R.C., Moore R.W., Ingall G.B., Peterson R.E. Androgenic deficiency in male rats treated with perfluorodecanoic acid. Toxicol Appl Pharmacol 1990, 104:322-333.
12. Braithwaite D., Moore D.H., Lustig R.H., et al. Socioeconomic status in relation to early menarche among black and white girls. Cancer Causes Control 2009, 20:713-720.
13. Britton J.A., Wolff M.S., Lapinski R., et al. Characteristics of pubertal development in a multi-ethnic population of nine-year-old girls. Ann Epidemiol 2004, 14:179-187.
14. Calafat A.M., Wong L.Y., Kuklenyik Z., Reidy J.A., Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 2007, 115:1596-1602.
15. Cook J.C., Murray S.M., Frame S.R., Hurtt M.E. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. Toxicol Appl Pharmacol 1992, 113:209-217.
16. Du Y.B., Shi X.J., Liu C.S., Yu K., Zhou B.S. Chronic effects of water-borne PFOS exposure on growth, survival and hepatotoxicity in zebrafish: a partial life-cycle test. Chemosphere 2009, 74:723-729.
17. Fei C., McLaughlin J.K., Tarone R.E., Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 2007, 115:1677-1682.
18. Freedman D.S., Khan L.K., Serdula M.K., Dietz W.H., Srinivasan S.R., Berenson G.S. Relation of age at menarche to race, time period, and anthropometric dimensions: the Bogalusa Heart Study. Pediatrics 2002, 110:e43.
19. Golding J., Pembrey M., Jones R. ALSPAC-the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatr Perinat Epidemiol 2001, 15:74-87.
20. Golub M.S., Collman G.W., Foster P.M.D., et al. Public health implications of altered puberty timing. Pediatrics 2008, 121:S218-S230.
21. November 21, 2002 report: Hazard Assessment of Perfluorooctane sulfonate (PFOS) and its salts. Organisation for Economic Co-operation and Development. ENV/JM/RD(2002) 17/FINAL.
22. Houde M., Martin J.W., Letcher R.J., Solomon K.R., Muir D.C. Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol 2006, 40:3463-3473.
23. Inoue K., Okada F., Ito R., et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 2004, 112:1204-1207.
24. Kuklenyik Z., Needham L.L., Calafat A.M. Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Anal Chem 2005, 77:6085-6091.
25. Lau C., Thibodeaux J.R., Hanson R.G., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 2003, 74:382-392.
26. Liu R.C., Hahn C., Hurtt M.E. The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro. Fundam Appl Toxicol 1996, 30:102-108.
27. Liu C.S., Du Y.B., Zhou B.S. Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes. Aquat Toxicol 2007, 85:267-277.
28. McDowell M.A., Brody D.J., Hughes J.P. Has age at menarche changed? Results from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. J Adolesc Health 2007, 40:227-231.
29. Olsen G.W., Gilliland F.D., Burlew M.M., Burris J.M., Mandel J.S., Mandel J.H. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 1998, 40:614-622.
30. Olsen G.W., Chang S.C., Noker P.E., et al. A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans. Toxicology 2009, 256:65-74.
31. OPCS Standard Occupational Classification London: HMSO 1991.
32. Pinney S.M., Windham G.C., Biro F.M., et al. Perfluorooctanoic acid (PFOA) and pubertal maturation in young girls. The International Society for Environmental Epidemiology. Dublin, Ireland 2009.
33. Remacle C., Bieswal F., Reusens B. Programming of obesity and cardiovascular disease. Int J Obes Relat Metab Disord 2004, 28(Suppl 3):S46-S53.
34. Rhind S.M., Rae M.T., Brooks A.N. Effects of nutrition and environmental factors on the fetal programming of the reproductive axis. Reproduction 2001, 122:205-214.
35. Rubin C., Maisonet M., Kieszak S., et al. Timing of maturation and predictors of menarche in girls enrolled in a contemporary British cohort. Paediatr Perinat Epidemiol 2009, 23(5)(Sep):492-504.
36. Shi Z., Zhang H., Ding L., Feng Y., Xu M., Dai J. The effect of perfluorododecanonic acid on endocrine status, sex hormones and expression of steroidogenic genes in pubertal female rats. Reprod Toxicol 2009, 27:352-359.
37. Sibinski L.J. Two-year oral (diet) toxicity/carcinogenicity study of fluorochemical FC-143 (perfluorooctane ammonium carboxylate) in rats. Report prepared for 3M, St. Paul, Minnesota by Riker Laboratories Inc. Study No. 0281CR0012; 8EHQ-1087-0394, October 16, 1987 1987.
38. Thibodeaux J.R., Hanson R.G., Rogers J.M., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 2003, 74:369-381.
39. Tilton S.C., Orner G.A., Benninghoff A.D., et al. Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout. Environ Health Perspect 2008, 116:1047-1055.
40. Wang Y. Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics 2002, 110:903-910.
41. Wei Y., Dai J., Liu M., et al. Estrogen-like properties of perfluorooctanoic acid as revealed by expressing hepatic estrogen-responsive genes in rare minnows (Gobiocypris rarus). Environ Toxicol Chem 2007, 26:2440-2447.
42. Wei Y., Liu Y., Wang J., Tao Y., Dai J. Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus). Toxicol Appl Pharmacol 2008, 226:285-297.
43. Wolf C.J., Fenton S.E., Schmid J.E., et al. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci 2007, 95:462-473.
44. Wu T., Mendola P., Buck G.M. Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics 2002, 110:752-757.
45. Wyshak G., Frisch R.E. Evidence for a secular trend in age of menarche. N Engl J Med 1982, 306:1033-1035.
46. Zacharias L., Wurtman R.J. Age at menarche. Genetic and environmental influences. New Engl j med 1969, 280:868-875.